Question 1

How many shares of LIXT does CITADEL ADVISORS LLC own?

Accepted Answer

CITADEL ADVISORS LLC previously held 0 shares of LIXT (LIXTE BIOTECHNOLOGY HLDGS IN) before exiting the position in 2026-Q2.

Question 2

What is CITADEL ADVISORS LLC's LIXT position worth?

Accepted Answer

CITADEL ADVISORS LLC's LIXT position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is CITADEL ADVISORS LLC buying or selling LIXT?

Accepted Answer

In 2026-Q2, CITADEL ADVISORS LLC exited their LIXT position entirely (-100.0% change in shares).

Question 4

When did CITADEL ADVISORS LLC first buy LIXT?

Accepted Answer

Based on available 13F filings, CITADEL ADVISORS LLC first reported a position in LIXT in 2021-Q1. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$7.42	0
2026-Q1	Increased	56,557	+301.3%	$173,630	0.0%	$2.85	25
2025-Q4	New	14,093	-	$55,385	0.0%	$3.90	32
2025-Q2	Exited	0	-100.0%	$0	0.0%	$0.71	0
2025-Q1	New	24,522	-	$29,672	0.0%	$1.27	30
2022-Q3	Exited	0	-100.0%	$0	0.0%	$5.50	0
2022-Q2	New	30,063	-	$23,000	0.0%	$7.30	29
2021-Q3	Exited	0	-100.0%	$0	0.0%	$20.40	0
2021-Q2	Decreased	12,394	-48.0%	$38,000	0.0%	$30.60	0
2021-Q1	New	23,813	-	$79,000	0.0%	$32.20	33

LIXT10 quarters

LIXT
10 quarters